From Lydia Pinkham to Bob Dole: What the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Kennedy Institute of Ethics Journal 12 (2):141-158 (2002)
: From its founding in 1847, the AMA divided drugs into "ethical" and "unethical" preparations. Those that were ethical had a known composition and were advertised only to the profession. Others, patent medicines (technically proprietary drugs, whose trademarks were protected by copyright), were sold directly to the public. In spite of the AMA's efforts to ban the advertising and sale of these nostrums, proprietary drugs flourished during the nineteenth century. Starting in 1900, however, three major societal trends combined to bolster the AMA's campaign, and by 1920 almost all advertising was directed to physicians, who would then prescribe medications to their patients. This ban on advertising pharmaceuticals directly to the public remained virtually unchanged until approximately 1980. Since then, it has slowly eroded and, as recently as 1997, the FDA created guidelines for pharmaceutical companies to advertise on television. What does this change say about the profession of medicine, the role of the physician in society, and the doctor-patient relationship? Using a comparative historical approach, this paper examines these issues
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
David S. Waller (2012). “Truth in Advertising”: The Beginning of Advertising Ethics in Australia. Journal of Mass Media Ethics 27 (1):46-56.
Penny M. Simpson, Gene Brown & Robert E. Widing (1998). The Association of Ethical Judgment of Advertising and Selected Advertising Effectiveness Response Variables. Journal of Business Ethics 17 (2):125-136.
Pepijn K. C. van de Pol & Frank G. A. de Bakker (2010). Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility? Journal of Business Ethics 94 (2):211-224.
Shaili Jain (2007). Understanding Physician-Pharmaceutical Industry Interactions. Cambridge University Press.
Marc A. Rodwin (2010). Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal. Journal of Law, Medicine and Ethics 38 (4):807-815.
Jin Seong Park & Jean M. Grow (2008). The Social Reality of Depression: Dtc Advertising of Antidepressants and Perceptions of the Prevalence and Lifetime Risk of Depression. [REVIEW] Journal of Business Ethics 79 (4):379 - 393.
Ashish Chandra & Gary A. Holt (1999). Pharmaceutical Advertisements: How They Deceive Patients. [REVIEW] Journal of Business Ethics 18 (4):359 - 366.
Richard F. Beltramini (2006). Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. Journal of Business Ethics 63 (4):333 - 343.
Uvonne Lau (2005). Is Banning Direct to Consumer Advertising of Prescription Medicine Justified Paternalism? Journal of Bioethical Inquiry 2 (2):69-74.
Added to index2009-01-28
Total downloads10 ( #145,646 of 1,100,500 )
Recent downloads (6 months)8 ( #27,510 of 1,100,500 )
How can I increase my downloads?